Cargando…

The advanced lung cancer inflammation index is a novel independent prognosticator in colorectal cancer patients after curative resection

BACKGROUND: The advanced lung cancer inflammation index (ALI), which comprehensively evaluates the patient body composition and inflammation/nutritional status, is reportedly associated with the patient outcome in lung cancer. However, the clinical significance in colorectal cancer (CRC) patients af...

Descripción completa

Detalles Bibliográficos
Autores principales: Horino, Taichi, Tokunaga, Ryuma, Miyamoto, Yuji, Hiyoshi, Yukiharu, Akiyama, Takahiko, Daitoku, Nobuya, Sakamoto, Yuki, Yoshida, Naoya, Baba, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786697/
https://www.ncbi.nlm.nih.gov/pubmed/35106418
http://dx.doi.org/10.1002/ags3.12499
_version_ 1784639171948707840
author Horino, Taichi
Tokunaga, Ryuma
Miyamoto, Yuji
Hiyoshi, Yukiharu
Akiyama, Takahiko
Daitoku, Nobuya
Sakamoto, Yuki
Yoshida, Naoya
Baba, Hideo
author_facet Horino, Taichi
Tokunaga, Ryuma
Miyamoto, Yuji
Hiyoshi, Yukiharu
Akiyama, Takahiko
Daitoku, Nobuya
Sakamoto, Yuki
Yoshida, Naoya
Baba, Hideo
author_sort Horino, Taichi
collection PubMed
description BACKGROUND: The advanced lung cancer inflammation index (ALI), which comprehensively evaluates the patient body composition and inflammation/nutritional status, is reportedly associated with the patient outcome in lung cancer. However, the clinical significance in colorectal cancer (CRC) patients after curative resection remains unclear. METHODS: A total of 813 CRC patients after curative resection between April 2005 and June 2019 in a single institution were retrospectively enrolled. The association of the preoperative ALI (calculated as follows: body mass index × albumin value/neutrophil‐to‐lymphocyte ratio) with clinicopathological factors, postoperative complications, and survival was analyzed. RESULTS: A low ALI was significantly associated with male gender, older age, a higher depth of tumor invasion, progressed TNM stage, and preoperative carcinoembryonic antigen (CEA) positivity. Both postoperative complications and severe complications occurred more frequently in the ALI‐low group than in the ALI‐high group (P < .001 and P < .001, respectively), especially postoperative complications in stage III patients (P < .001) and severe complications in stages II and III patients (P = .024 and P = .004, respectively). In addition, a low ALI was an independent predictor of a poor overall survival (hazard ratio: 2.30, 95% confidence interval: 1.52–3.50, P < .001) and relapse‐free survival (hazard ratio: 1.73, 95% confidence interval: 1.22–2.44, P = .002), especially in older patients, and in patients without lymph node metastasis or severe postoperative complications. CONCLUSION: This study suggests that preoperative ALI may serve as a novel independent predictive index for severe postoperative complications and recurrence in CRC patients after curative resection.
format Online
Article
Text
id pubmed-8786697
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-87866972022-01-31 The advanced lung cancer inflammation index is a novel independent prognosticator in colorectal cancer patients after curative resection Horino, Taichi Tokunaga, Ryuma Miyamoto, Yuji Hiyoshi, Yukiharu Akiyama, Takahiko Daitoku, Nobuya Sakamoto, Yuki Yoshida, Naoya Baba, Hideo Ann Gastroenterol Surg Original Articles BACKGROUND: The advanced lung cancer inflammation index (ALI), which comprehensively evaluates the patient body composition and inflammation/nutritional status, is reportedly associated with the patient outcome in lung cancer. However, the clinical significance in colorectal cancer (CRC) patients after curative resection remains unclear. METHODS: A total of 813 CRC patients after curative resection between April 2005 and June 2019 in a single institution were retrospectively enrolled. The association of the preoperative ALI (calculated as follows: body mass index × albumin value/neutrophil‐to‐lymphocyte ratio) with clinicopathological factors, postoperative complications, and survival was analyzed. RESULTS: A low ALI was significantly associated with male gender, older age, a higher depth of tumor invasion, progressed TNM stage, and preoperative carcinoembryonic antigen (CEA) positivity. Both postoperative complications and severe complications occurred more frequently in the ALI‐low group than in the ALI‐high group (P < .001 and P < .001, respectively), especially postoperative complications in stage III patients (P < .001) and severe complications in stages II and III patients (P = .024 and P = .004, respectively). In addition, a low ALI was an independent predictor of a poor overall survival (hazard ratio: 2.30, 95% confidence interval: 1.52–3.50, P < .001) and relapse‐free survival (hazard ratio: 1.73, 95% confidence interval: 1.22–2.44, P = .002), especially in older patients, and in patients without lymph node metastasis or severe postoperative complications. CONCLUSION: This study suggests that preoperative ALI may serve as a novel independent predictive index for severe postoperative complications and recurrence in CRC patients after curative resection. John Wiley and Sons Inc. 2021-09-14 /pmc/articles/PMC8786697/ /pubmed/35106418 http://dx.doi.org/10.1002/ags3.12499 Text en © 2021 The Authors. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterology https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Horino, Taichi
Tokunaga, Ryuma
Miyamoto, Yuji
Hiyoshi, Yukiharu
Akiyama, Takahiko
Daitoku, Nobuya
Sakamoto, Yuki
Yoshida, Naoya
Baba, Hideo
The advanced lung cancer inflammation index is a novel independent prognosticator in colorectal cancer patients after curative resection
title The advanced lung cancer inflammation index is a novel independent prognosticator in colorectal cancer patients after curative resection
title_full The advanced lung cancer inflammation index is a novel independent prognosticator in colorectal cancer patients after curative resection
title_fullStr The advanced lung cancer inflammation index is a novel independent prognosticator in colorectal cancer patients after curative resection
title_full_unstemmed The advanced lung cancer inflammation index is a novel independent prognosticator in colorectal cancer patients after curative resection
title_short The advanced lung cancer inflammation index is a novel independent prognosticator in colorectal cancer patients after curative resection
title_sort advanced lung cancer inflammation index is a novel independent prognosticator in colorectal cancer patients after curative resection
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786697/
https://www.ncbi.nlm.nih.gov/pubmed/35106418
http://dx.doi.org/10.1002/ags3.12499
work_keys_str_mv AT horinotaichi theadvancedlungcancerinflammationindexisanovelindependentprognosticatorincolorectalcancerpatientsaftercurativeresection
AT tokunagaryuma theadvancedlungcancerinflammationindexisanovelindependentprognosticatorincolorectalcancerpatientsaftercurativeresection
AT miyamotoyuji theadvancedlungcancerinflammationindexisanovelindependentprognosticatorincolorectalcancerpatientsaftercurativeresection
AT hiyoshiyukiharu theadvancedlungcancerinflammationindexisanovelindependentprognosticatorincolorectalcancerpatientsaftercurativeresection
AT akiyamatakahiko theadvancedlungcancerinflammationindexisanovelindependentprognosticatorincolorectalcancerpatientsaftercurativeresection
AT daitokunobuya theadvancedlungcancerinflammationindexisanovelindependentprognosticatorincolorectalcancerpatientsaftercurativeresection
AT sakamotoyuki theadvancedlungcancerinflammationindexisanovelindependentprognosticatorincolorectalcancerpatientsaftercurativeresection
AT yoshidanaoya theadvancedlungcancerinflammationindexisanovelindependentprognosticatorincolorectalcancerpatientsaftercurativeresection
AT babahideo theadvancedlungcancerinflammationindexisanovelindependentprognosticatorincolorectalcancerpatientsaftercurativeresection
AT horinotaichi advancedlungcancerinflammationindexisanovelindependentprognosticatorincolorectalcancerpatientsaftercurativeresection
AT tokunagaryuma advancedlungcancerinflammationindexisanovelindependentprognosticatorincolorectalcancerpatientsaftercurativeresection
AT miyamotoyuji advancedlungcancerinflammationindexisanovelindependentprognosticatorincolorectalcancerpatientsaftercurativeresection
AT hiyoshiyukiharu advancedlungcancerinflammationindexisanovelindependentprognosticatorincolorectalcancerpatientsaftercurativeresection
AT akiyamatakahiko advancedlungcancerinflammationindexisanovelindependentprognosticatorincolorectalcancerpatientsaftercurativeresection
AT daitokunobuya advancedlungcancerinflammationindexisanovelindependentprognosticatorincolorectalcancerpatientsaftercurativeresection
AT sakamotoyuki advancedlungcancerinflammationindexisanovelindependentprognosticatorincolorectalcancerpatientsaftercurativeresection
AT yoshidanaoya advancedlungcancerinflammationindexisanovelindependentprognosticatorincolorectalcancerpatientsaftercurativeresection
AT babahideo advancedlungcancerinflammationindexisanovelindependentprognosticatorincolorectalcancerpatientsaftercurativeresection